Pharmacological Management of Gestational Diabetes Mellitus Riki BergelEran HadarMoshe Hod Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors) 17 October 2016 Article: 118
Marijuana Use and Type 2 Diabetes Mellitus: a Review Stephen Sidney Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors) 17 October 2016 Article: 117
Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus Gül BahtiyarDavid GuttermanHarold Lebovitz Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors) Open access 12 October 2016 Article: 116
Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes Nalani HavilandJohn WalshTimothy S. Bailey Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor) 07 October 2016 Article: 115
Sitting Less and Moving More: Improved Glycaemic Control for Type 2 Diabetes Prevention and Management Paddy C. DempseyNeville OwenDavid W. Dunstan Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors) 03 October 2016 Article: 114
Self-Care Disparities Among Adults with Type 2 Diabetes in the USA Lindsay Satterwhite MayberryErin M. BergnerChandra Y. Osborn Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors) 26 September 2016 Article: 113
Access to Diabetes Care for Populations Experiencing Homelessness: an Integrated Review Brandi M. WhiteAyaba LoganGayenell S. Magwood Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston and ME McDonnell, Section Editors) 24 September 2016 Article: 112
Does Zinc Really “Metal” with Diabetes? The Epidemiologic Evidence Manuel RuzFernando CarrascoPamela Rojas Diabetes Epidemiology (NM Maruthur, Section Editor) 24 September 2016 Article: 111
Restoring Regulatory T Cells in Type 1 Diabetes Allyson SpenceQizhi Tang Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 23 September 2016 Article: 110
The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy Chris FrakerAllison L. Bayer Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 23 September 2016 Article: 109
Racial/Ethnic Residential Segregation, Obesity, and Diabetes Mellitus Kiarri N. KershawAshley E. Pender Obesity (J McCaffery, Section Editor) 23 September 2016 Article: 108
Integrated Cardio-Respiratory Control: Insight in Diabetes Luciano BernardiLucio Bianchi Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor) 23 September 2016 Article: 107
Sleep Duration and Diabetes Risk: Population Trends and Potential Mechanisms Michael A. GrandnerAzizi SeixasSundeep Shenoy Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors) 23 September 2016 Article: 106
Imaging Atherosclerosis in Diabetes: Current State Sina RahmaniRine NakanishiMatthew J. Budoff Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors) 23 September 2016 Article: 105
Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy G. CurrieC. Delles Microvascular Complications—Nephropathy (AP Maxwell, Section Editor) 23 September 2016 Article: 104
Caring for People with Diabetes at the End of Life Trisha DunningNicole DugganSally Savage Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston and ME McDonnell, Section Editors) 22 September 2016 Article: 103